Female Cialis ( Tadalafil )

Buy Female Cialis (Tadalafil) without prescription in Canada

In our Canadian pharmacy, you can buy Female Cialis (Tadalafil) without a prescription, with delivery across Canada within 5‑14 days. Discreet and anonymous packaging.

Female Cialis (tadalafil) is a long‑acting oral phosphodiesterase type 5 (PDE5) inhibitor used off‑label for the management of female sexual arousal disorder (FSAD). It works by relaxing the smooth muscle in the pelvic blood vessels and increasing blood flow to the clitoris and vaginal tissues during sexual stimulation, thereby enhancing genital sensitivity, lubrication, and the capacity for arousal and orgasm. Its hallmark is a long half‑life of approximately 17.5 hours, providing a therapeutic window of up to 36 hours that allows for greater spontaneity compared with shorter‑acting PDE5 inhibitors.

Usual adult dose: The recommended starting dose is 10 mg taken orally as needed, approximately 30 to 60 minutes before anticipated sexual activity, with or without food. Depending on individual efficacy and tolerability, the dose may be increased to a maximum of 20 mg once daily. The maximum recommended dosing frequency is once per day. Doses above 20 mg are not recommended. Sexual stimulation is required for the medication to be effective; it does not increase sexual desire on its own.

Dosage form: Oral film‑coated tablets: 10 mg and 20 mg of tadalafil. The 10 mg tablet is typically almond‑shaped and yellow; the 20 mg tablet is almond‑shaped and yellow.

Onset of action: Tadalafil is rapidly absorbed, with peak plasma concentrations reached at a median of 2 hours (range 0.5–6 hours). Many women notice an improvement in genital arousal within 30 to 45 minutes of taking a dose on an empty stomach. Food does not significantly affect absorption.

Duration of action: The therapeutic effect for sexual arousal can persist for up to 36 hours after a single dose, providing a substantially longer window of spontaneity than other PDE5 inhibitors. The elimination half‑life of tadalafil is approximately 17.5 hours.

Alcohol recommendation: Alcohol consumption should be limited or avoided while taking Female Cialis. Alcohol can reduce sexual responsiveness, lower blood pressure, and increase the risk of side effects such as headache, dizziness, and flushing. Heavy alcohol intake is particularly discouraged, especially at the 20 mg dose.

Most common side effects: Headache (11‑15%), dyspepsia (indigestion, 8‑10%), back pain (3‑6%), myalgia (muscle pain, 3‑6%), nasal congestion (2‑3%), flushing (2‑3%), and dizziness. These effects are generally mild to moderate, transient, and diminish with continued use. Rare but serious side effects include priapism (a prolonged, painful clitoral erection lasting more than 4 hours, which is a medical emergency), sudden vision loss (non‑arteritic anterior ischaemic optic neuropathy, NAION), and sudden hearing loss. Safety and efficacy in women have not been evaluated to the same rigorous standard as for male erectile dysfunction.

Would you like to try Female Cialis (Tadalafil) without a prescription?

General Information about Female Cialis (Tadalafil)

• INN (International Nonproprietary Name): Tadalafil
• Brand names available in Canada: Female Cialis is not an approved or marketed brand in Canada. Tadalafil is legally available in Canada only for male erectile dysfunction (ED) and benign prostatic hyperplasia under the brand name Cialis® (Eli Lilly Canada Inc.) and as generic tadalafil tablets. Female Cialis is an internationally sourced product used off‑label for female sexual arousal disorder and supplied by our pharmacy through the international supply chain for personal importation.
• ATC code: G04BE08 (urologicals, drugs used in erectile dysfunction).
• Dosage forms and strengths: Oral film‑coated tablets: 10 mg and 20 mg of tadalafil.
• Manufacturers in Canada: None. Female Cialis is not manufactured in Canada. The active ingredient tadalafil is manufactured by Eli Lilly Canada Inc. (Cialis) and various generic companies for the male indications. The Female Cialis brand is manufactured internationally and imported for personal use.
• Registration status in Canada: Not marketed in Canada for female use. Tadalafil is approved by Health Canada only for male ED and BPH. No Health Canada approval exists for female sexual dysfunction. The product is imported for personal use under a valid prescription.
• OTC / Rx classification: Prescription only (Rx). Tadalafil is a Schedule I drug under the Controlled Drugs and Substances Act. A valid prescription from a licensed Canadian healthcare professional is required.

Mechanism of Action and Pharmacology

Tadalafil is a potent, selective, and reversible inhibitor of cyclic guanosine monophosphate (cGMP)‑specific phosphodiesterase type 5 (PDE5). In women, PDE5 is present in the clitoral corpus cavernosum, vaginal smooth muscle, and pelvic vasculature. During sexual stimulation, nitric oxide is released from nerve endings and endothelial cells in these tissues, activating guanylate cyclase and raising intracellular cGMP. This leads to smooth‑muscle relaxation, vasodilation, and increased blood flow, which promotes clitoral engorgement, vaginal lubrication, and heightened sensitivity. By preventing the breakdown of cGMP, tadalafil amplifies and prolongs this genital vasocongestive response, potentially enhancing arousal, orgasm, and overall sexual satisfaction. Tadalafil has a 700‑fold selectivity for PDE5 over PDE6 (retina), contributing to a low incidence of visual disturbances. Its long half‑life of approximately 17.5 hours, resulting from slow hepatic metabolism primarily by CYP3A4, allows for a 36‑hour window of effectiveness. The drug and its inactive catechol metabolite are excreted mainly in the faeces (61%) and urine (36%). Tadalafil does not increase sexual desire in the absence of stimulation; it only facilitates the physiological arousal response when erotic stimuli are present.

Indications

• Female Cialis is used off‑label for the management of female sexual arousal disorder (FSAD), a condition characterised by persistent or recurrent inability to attain or maintain sufficient genital lubrication, swelling, or pleasurable sensation during sexual activity, causing marked distress or interpersonal difficulty. The medication is intended to improve genital blood flow and enhance the capacity for arousal and orgasm.
• This product is not approved by Health Canada for any female indication. Safety and efficacy in women have not been established to the same rigorous standard as for male ED. Use in women is based on limited clinical trial evidence and clinical experience.
• Not indicated for use in men, children, or adolescents under 18 years of age, or in pregnant or breastfeeding women.

Important Warnings and Precautions

At‑risk groups

• Pregnancy and breastfeeding: Female Cialis is not indicated for use by pregnant or breastfeeding women. The safety of tadalafil during pregnancy and lactation has not been studied. Effective contraception should be used if pregnancy is a possibility.
• Paediatrics (< 18 years): Not indicated. Safety and efficacy have not been established in children.
• Elderly: No dose adjustment is required based on age alone. However, elderly women may be more sensitive to the vasodilatory effects, and the risk of orthostatic hypotension may be increased. A starting dose of 10 mg is recommended; the 20 mg dose should be used with caution.
• Cardiovascular disease: Sexual activity carries a degree of cardiac risk. Tadalafil has vasodilatory properties and can cause mild, transient decreases in blood pressure. It is contraindicated in women with severe cardiovascular disease, including unstable angina, severe heart failure, and recent myocardial infarction or stroke (within the last 6 months).
• Use with nitrates — absolutely contraindicated: Tadalafil potentiates the hypotensive effects of organic nitrates and nitric oxide donors (e.g., nitroglycerin, isosorbide mononitrate, amyl nitrite). Concomitant use can cause a life‑threatening drop in blood pressure. This contraindication applies to all doses and formulations.
• Use with guanylate cyclase stimulators — contraindicated: Concomitant use with riociguat (Adempas®) is contraindicated due to the risk of severe hypotension.
• Priapism: Although rare in women, prolonged clitoral erection (clitoral priapism) has been reported with PDE5 inhibitors and is a urological emergency that can lead to tissue damage. Women experiencing a painful, prolonged clitoral erection lasting more than 4 hours should seek immediate medical attention.
• Vision loss: Non‑arteritic anterior ischaemic optic neuropathy (NAION), a cause of sudden vision loss, has been reported rarely in temporal association with PDE5 inhibitor use. The risk may be increased in individuals with a small cup‑to‑disc ratio, hypertension, diabetes, or smoking. Stop the drug and seek immediate care if sudden vision loss occurs.
• Hearing loss: Sudden decrease or loss of hearing has been reported. Discontinue and seek prompt medical attention.
• Renal impairment: For as‑needed use, no dose adjustment is needed in mild to moderate renal impairment (CrCl 31–80 mL/min). In severe renal impairment (CrCl ≤ 30 mL/min), the maximum dose is 10 mg once every 48 hours; the 20 mg dose is contraindicated in severe renal impairment. Once‑daily use is not recommended.
• Hepatic impairment: In mild to moderate hepatic impairment (Child‑Pugh A or B), the maximum dose is 10 mg; the 20 mg dose is not recommended. Tadalafil has not been studied in severe hepatic impairment and is contraindicated.
• Alpha‑blockers and antihypertensives: Additive hypotension may occur. Women on alpha‑blockers should be stabilised before initiating tadalafil, and the starting dose should be 10 mg. The 20 mg dose should be avoided in combination with alpha‑blockers.
• Allergy: Do not take Female Cialis if you have a known hypersensitivity to tadalafil or any excipient in the tablet.

Driving and alcohol

Tadalafil may cause dizziness or blurred vision. Patients should know how they react before driving or operating machinery. Alcohol should be limited, as it may impair sexual response, lower blood pressure, and increase the risk of headache, dizziness, and orthostatic hypotension.

Dosage Instructions

• Standard adult dose: The recommended starting dose is 10 mg taken orally as needed, approximately 30 to 60 minutes before sexual activity, with or without food. Based on individual efficacy and tolerability, the dose may be increased to a maximum of 20 mg once daily. The maximum dosing frequency is once per day. Do not exceed one dose in 24 hours.
• Special populations: In severe renal impairment (CrCl ≤ 30 mL/min), the maximum dose is 10 mg once every 48 hours. In mild to moderate hepatic impairment (Child‑Pugh A or B), the maximum dose is 10 mg. The 20 mg dose is contraindicated in these populations.
• Administration: Swallow the tablet whole with a glass of water. Tadalafil may be taken with or without food; a high‑fat meal does not affect absorption but may delay the peak effect slightly. Sexual stimulation is required for the medication to work; it does not cause arousal without erotic stimuli.
• Missed dose: Female Cialis is taken as needed only; a missed dose concept does not apply. Do not take more than one dose per day.

Side Effects and Contraindications

• Very common side effects (≥ 10%): Headache and dyspepsia.
• Common side effects (1‑10%): Back pain, myalgia, nasal congestion, flushing, dizziness, and pain in the limbs. Back pain and myalgia typically occur 12 to 24 hours after dosing and resolve within 48 hours.
• Serious adverse reactions: Priapism (clitoral), sudden vision loss (NAION), sudden hearing loss, and cardiovascular events (myocardial infarction, stroke) temporally associated with sexual activity. Hypotension and syncope may occur, especially with higher doses or with alcohol.
• Contraindications: Concomitant use of organic nitrates in any form, or nitric oxide donors. Concomitant use of riociguat. Known hypersensitivity to tadalafil. Severe cardiovascular disease or conditions in which sexual activity is inadvisable. Recent myocardial infarction or stroke (within 6 months). Severe hepatic impairment. The 20 mg dose is contraindicated in severe renal impairment and in combination with alpha‑blockers.

Drug Interactions

• Nitrates and nitric oxide donors — contraindicated: See warnings.
• Guanylate cyclase stimulators — contraindicated: Riociguat.
• Alpha‑blockers: Additive hypotension; start tadalafil at 10 mg, avoid the 20 mg dose with alpha‑blockers.
• Potent CYP3A4 inhibitors (e.g., ritonavir, ketoconazole): Significantly increase tadalafil levels. Maximum dose 10 mg, not more than once every 72 hours; the 20 mg dose is contraindicated with these inhibitors.
• Moderate CYP3A4 inhibitors (e.g., erythromycin, fluconazole): May increase exposure; avoid the 20 mg dose.
• Antihypertensives: Additive blood‑pressure‑lowering effect; monitor.
• Alcohol: Increases risk of hypotension and headache; limit intake.

Practical Advice

• Administration: Take the tablet at least 30 minutes before sexual activity. It can be taken with or without food. Do not take more than one dose per day. Sexual stimulation is necessary; the medication does not increase desire on its own. If you experience side effects such as headache or muscle pain, consult your doctor; these often improve with continued use or dose reduction.
• Monitoring: No routine laboratory monitoring is required. Medical evaluation is recommended before starting therapy, especially at the 20 mg dose. Seek immediate attention for clitoral priapism, sudden vision or hearing loss, or chest pain during sexual activity.
• Storage: Store at room temperature (15‑30 °C) in a dry place, protected from moisture and heat. Keep out of the reach and sight of children.
• Lifestyle: Address underlying factors that may affect sexual function: manage stress, improve sleep, maintain a healthy diet and exercise routine, and consider pelvic floor therapy or psychological counselling. Avoid heavy alcohol intake. Do not combine with other PDE5 inhibitors. Inform all healthcare providers of tadalafil use, especially if you require emergency treatment for chest pain, as nitrates are contraindicated.
• Emergency: If you develop a prolonged, painful clitoral erection lasting > 4 hours, sudden vision or hearing loss, or chest pain, stop the medication and go to the nearest emergency department.

Alternative Medications

• Sildenafil (Viagra®): Another PDE5 inhibitor used off‑label for FSAD, with a shorter duration of action (4‑6 hours). It may be preferred when a shorter‑acting agent is desired.
• Flibanserin (Addyi®): A multifunctional serotonin agonist/antagonist approved in the United States for acquired, generalised hypoactive sexual desire disorder (HSDD) in premenopausal women. It is taken daily at bedtime and primarily improves sexual desire, not arousal. It is not marketed in Canada.
• Bremelanotide (Vyleesi®): A melanocortin receptor agonist approved in the US for HSDD, administered by subcutaneous injection 45 minutes before sexual activity. It is not approved or available in Canada.
• Topical vaginal preparations: Vaginal estrogen therapy (for postmenopausal women) and non‑hormonal moisturisers/lubricants are first‑line for vulvovaginal atrophy‑related arousal difficulties.
• Psychosexual therapy and pelvic floor therapy: Cognitive‑behavioural therapy, mindfulness, and pelvic floor muscle training can significantly improve arousal and orgasm in women with FSAD, and are recommended as part of a comprehensive management plan.
• Off‑label use of other agents: Bupropion, buspirone, and oxytocin have been studied in limited settings; evidence is insufficient to recommend routine use.

Clinical Efficacy

The efficacy of PDE5 inhibitors in women with FSAD is inconsistent and has not reached the level of evidence required for regulatory approval. Several randomised controlled trials have evaluated sildenafil and tadalafil in pre‑ and postmenopausal women. A 2008 systematic review and meta‑analysis found a modest benefit of sildenafil in women with FSAD, particularly those with concomitant antidepressant‑induced sexual dysfunction; improvements in arousal, lubrication, and orgasm were observed, but global sexual satisfaction did not consistently improve. Tadalafil has been studied in smaller trials, with mixed results: some women report improved genital sensation and arousal, but placebo‑controlled data are limited. Neither drug has received FDA or Health Canada approval for female sexual dysfunction. The off‑label use of these agents is based on the physiological rationale that increased genital blood flow should enhance arousal; however, female sexual response is complex and influenced by psychological, relational, and hormonal factors, which may explain the variability in outcomes. Female Cialis provides a pragmatic option for those who wish to try PDE5 inhibition under medical supervision, with the understanding that the response is not guaranteed and the safety in women is extrapolated from extensive male data.

Important:

Female Cialis (tadalafil) is a prescription medication that has not been approved by Health Canada for female sexual arousal disorder. It should be used only under the supervision of a qualified healthcare professional. The most critical safety warning is that tadalafil must never be taken with any form of organic nitrate (e.g., nitroglycerin, amyl nitrite, “poppers”); this combination can cause a severe, sudden, and potentially fatal drop in blood pressure. If you experience chest pain or a prolonged, painful clitoral erection lasting longer than 4 hours, stop using the medication and seek emergency medical attention immediately. Do not exceed one dose per day. Sexual activity may carry a cardiac risk in women with pre‑existing cardiovascular disease. This product is for adult women and is not intended for use by men or children. If you are taking alpha‑blockers or medications that inhibit CYP3A4, you must inform your doctor; the dose of tadalafil must be reduced. Do not drink large amounts of alcohol. If you experience sudden vision or hearing loss, seek immediate medical attention. This information is not a substitute for professional medical advice, diagnosis, or treatment.

Get Female Cialis - Shipping across Canada